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ABSTRACT  Several  types  of cells  store  proteins  in  secretory  vesicles  from  which  they  are 
released  by  an  appropriate  stimulus.  It  might  be  expected  that  the  secretory  vesicles  in 
different  cell  types  use  similar  molecular  machinery.  Here  we  describe  a  transmembrane 
glycoprotein  (Mr ~100,000) that is present in secretory vesicles  in all neurons and endocrine 
cells  studied,  in  species  from  elasmobranch  fish  to  mammals,  and  in  neural  and  endocrine 
cell  lines.  It was  detected  by  cross-reactivity  with  monoclonal  antibodies  raised  to  highly 
purified cholinergic  synaptic vesicles  from the electric organ of fish.  By immunoprecipitation 
of  intact  synaptic  vesicles  and  electron  microscopic  immunoperoxidase  labeling,  we  have 
shown  that  the  antigenic  determinant  is  on  the  cytoplasmic  face  of the  synaptic  vesicles. 
However, the electrophoretic  mobility of the antigen synthesized  in the presence of tunica- 
mycin  is reduced  to  Mr -62,000,  which  suggests that the antigen  is glycosylated  and  must 
therefore span the vesicle  membrane. 
It now appears likely that protein secretion by cells can take 
two forms (14,  16, 38). Constitutive secretion, in which the 
rate  of protein  secretion  is  unregulated  and  quite  closely 
follows the rate of protein synthesis,  occurs in almost all cell 
types, including liver cells, lymphocytes, and yeast cells. In 
contrast, the rate of secretion is highly regulated in endocrine, 
exocrine, and neuronal cells which respond to external signals 
by releasing a  large amount of protein in a short period of 
time. Cells with regulated secretion store their secretory pro- 
teins in storage granules, whose probability of fusing with the 
plasma membrane is dramatically enhanced by the presence 
of a chemical or electrical signal.  Some cells appear to have 
both constitutive and regulated pathways (14,  16). Cells that 
have the regulated secretory pathway must express gene prod- 
ucts unique to this pathway, and proteins necessary for storage 
of secretory proteins, for calcium-dependent exocytosis, and 
for sorting of secretory proteins between the constitutive and 
regulated pathway, for example. Because of  differences among 
the exocrine, endocrine, and neuronal cells, one might also 
expect to find proteins specific for the secretory pathway in 
only one of the cell types. 
One potential way of identifying proteins involved in the 
regulated pathway is to generate antibodies specific  for the 
storage vesicles characteristic of that pathway. This approach 
has  been  successful  with  other  subcellular organelles.  For 
instance,  both  polyclonal and  monoclonal antibodies  now 
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exist that  allow the  relatively unambiguous  recognition of 
clathrin-coated membranes (27),  rough endoplasmic reticu- 
lum (28, 39), and the Golgi apparatus (6, 26, 28, 37, 39). The 
possibility of using a  similar approach to identify universal 
components of secretory vesicles was suggested by the obser- 
vation that a polyclonal antiserum to synaptic vesicles purified 
from the electric organ of a marine electric ray recognized not 
only nerve terminals in many areas of the mammalian brain, 
but also endocrine cells (18).  We have therefore prepared a 
library of monoclonal antibodies that recognize unique anti- 
gens in synaptic vesicles. By screening for an antigen shared 
by secretory vesicles in other cells with the regulated pathway 
we found that one monoclonal antibody (anti-SV2) recognizes 
a transmembrane glycoprotein that appears to be common to 
all  synaptic  vesicles  and  endocrine secretory vesicles.  The 
glycoprotein can be detected in  nerve terminals of species 
ranging  from  rat  and  frog to  cartilagenous fish.  Although 
exocrine cells have regulated secretion, they lack the antigen. 
The antibody and the protein it recognizes may provide a 
marker for the appearance and disappearance of the regulated 
pathway in neurons and endocrine cells. Because the antigenic 
site is on the cytoplasmic surface, the antibody is also useful 
for purification by immunoadsorption of membranous organ- 
elles that contain the glycoprotein. For example, it has already 
permitted the isolation of a subclass  of bovine brain coated 
vesicles that contains synaptic vesicle proteins (33). 
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Materials:  [35S]methionine was obtained  from Amersham Corp.  (Ar- 
lington  Heights,  IL). Rabbit  anti-mouse  Immunobeads and  protein  assay 
reagents were purchased  from Bio-Rad Laboratories (Richmond,  CA). Nitro- 
cellulose filters were obtained from Sartorius Filters, Inc. (Hayward, California), 
polyethylene glycol 4000  from Merck A. G.  (Darmstadt,  FRG),  fluorescein- 
conjugated goat anti-mouse lgG and rhodamine-conjugated  sheep anti-rabbit 
IgG from Cappel  Laboratories  (West Chester,  PA), horseradish  peroxidase- 
conjugated goat anti-mouse IgG and Tissue-Tek from Miles Laboratories Inc. 
(Elkhart, IN), and ultrapure  urea from Schwarz/Mann  (Spring Valley, NY). 10 
nm  gold-goat  anti-mouse  IgG  was  obtained  from  Jansen  Pbarmaceutica, 
Structure  Probe inc.  (West Chester,  PA), and Lowicryl K4M was purchased 
from Polysciences, Inc. (Warrington,  PA). All remaining chemicals, including 
molecular  weight  standards,  were  obtained  from Sigma  Chemical  Co.  (St. 
Louis, MO). 
Nerve growth factor (NGF)  ~  was generously donated by Dr. David Shelton, 
University of California, San Francisco (UCSF). 
Preparation of Monoclonal Antibodies:  Synaptic vesicles were 
purified from the elasmobranch  Discopyge ommata  as described for Narcine 
brasiliensis by Carlson et al. (10). Spleen cells from BALB/c mice immunized 
with synaptic vesicles were fused with SP2/O myeloma cells by use of polyeth- 
ylene glycol 4000 according to the modifications by Fazekas de St. Groth and 
Sheiddegger (12) of the procedure  of Kohler and Milstein (22). Supernatants 
from the hybridomas were screened for the presence of synaptic vesicle specific 
antibodies by use of a solid-phase radioimmunoassay  that compares binding of 
antibodies to elasmobranch synaptic vesicles and to a vesicle-free side fraction 
from the controlled pore glass column (8). 
Immunocytochemistry:  Tissues  from  animals  perfused  with  4% 
formaldehyde were infiltrated with phosphate-buffered saline (20 mM sodium 
phosphate,  150 mM sodium chloride, pH 7.4) (PBS) containing  10% sucrose, 
mounted in Tissue-Tek, quick-frozen with dichlorodifluoromethane,  and sec- 
tioned on a cryostat. Cells in culture were plated on poly-d-lysine-coated glass 
coverslips, and  fixed with  3.7% formalin  in  PBS  for  immunofluorescence. 
Monolayers of fixed cells or 10-12/~m  cryostat sections were preincubated  in 
1% bovine serum albumin in PBS (BSA-PBS) for 5 min, then incubated  with 
undiluted hybridoma supernatant for 1 h. After three brief rinses with 1% BSA- 
PBS, fluorescein-conjugated goat anti-mouse IgG in  1% BSA-PBS was added 
for  l  h.  Sections and  coverslips were washed  with  1%  BSA-PBS and  PBS, 
mounted in 90% glycerol, 10% PBS, 2.5% 1,4 diazobicyclo[2,2,2]octane (20) 
and viewed with fluorescein filters. When horseradish  peroxidase-conjugated 
lgG was used as a second antibody  on cryostat sections, 0.1% Triton  X-100 
was used in the  1%  BSA-PBS buffer throughout the incubations  and washes. 
After they  were rinsed  with PBS, the sections were reacted with 0.5  mg/ml 
diaminobenzidine  hydrochloride and 0.01% hydrogen peroxide in 0.05 M Tris, 
pH 7.6, until reaction product was visible. The sections were then dehydrated 
in ethanol, cleared in xylene, and mounted in Permount (Fisher Scientific Co., 
Fair Lawn, N  J). 
AtT-20  cells were  stained  for  adrenocorticotropin  (ACTH)  with  rabbit 
antiserum  generated  as described  by  Moore  et al.  (32) and affinity purified 
according to the method  of Mains and Eipper (29). The cells were fixed with 
3.7% formalin, pretreated with 0.25% Triton X-100 in PBS-BSA, and incubated 
with antiserum to ACTH, followed by rhodamine-conjugated  sheep anti-rabbit 
lgG. All rinses and antibody incubations  were done in 0.25% Triton  X-100 in 
PBS-BSA. 
lmmunoelectronmicroscopy  of electric organ nerve terminals  was done as 
described (5). 
Immunocytocbemistry  of Lowicryl-embedded tissue was done by a modifi- 
cation  of the  procedure  of Altman  et  al.  (1) and  is described  in  detail  by 
Valentino  et  aL  (Valentino,  K.  L.,  D.  A.  Crumvine,  and  L.  F.  Reichardt, 
manuscript submitted  for  publication).  In  short,  rat  brains  were  fixed by 
perfusion with 4% paraformaldehyde,  0.1% glutaraldehyde, and 2 mM CaCl2 
in 0.1  M cacodylate buffer. Brains were removed and fixed overnight  in the 
same fixative but without giutaraldehyde. Pieces of cerebellum were washed in 
0.1  M cacodylate buffer and stained en bloc with 2% aqueous uranyl acetate at 
4"C for 1-2 h. Tissue was dehydrated in graded series of ethanol and infiltrated 
with Lowicryl K4M as described (Valentino, K. L., D. A. Crumvine, and L. F. 
Reichardt, manuscript submitted for publication). Thin sections were collected 
on Formvar-coated  nickel grids, washed with 5% normal goat serum in PBS, 
and incubated with undiluted hybridoma supernatant for 20 rain. After a brief 
rinse with 5% normal goat serum-PBS, the sections were floated on a drop of 
undiluted  goat anti-mouse IgG adsorbed  to  10 nm colloidal gold for 5 min. 
Control  sections were incubated  with culture  medium and goat anti-mouse 
IgG-colloidal gold. Grids  were stained  with  2%  OsO4 and with  2%  uranyl 
t  Abbreviations used in this paper: mAb, monoclonal antibody; NGF, 
nerve growth factor. 
acetate. 
Random  fields from  both  the  glomerular  and  molecular  layers  of the 
cerebellum were photographed  at  15,200 X and printed  at a further  magnifi- 
cation of 2.5. 12 micrographs were chosen in which synapses could be clearly 
recognized  by  the  presence  of pre-  and  postsynaptic  densities.  Presynaptic 
terminals with intact plasma membranes (a total of 55 terminals) were outlined 
with  ink.  On  each  micrograph,  the  total  number of gold particles  and  the 
number of gold particles localized over the outlined  synapses were counted. 
The micrographs were then Xeroxed and weighed before and after the outlined 
synapses were cut out. The total number of  gold particles in all 12 micrographs 
(3,293 particles) was divided by the total weight of  the micrographs. This figure 
represents the density of the gold particles if they are randomly distributed but 
does not represent background  binding, since synaptic binding is included in 
this number. The number of  gold particles localized over the outlined synaptic 
terminals  was divided by the total weight of the synapses. An increase in the 
density of gold particles associated with synaptic terminals over average density 
represents a specific association of gold particles with presynaptic  structures. 
Control  sections incubated  with culture  medium and goat anti-mouse IgG- 
colloidal gold had <10 gold particles per micrograph. 
Iramunoblots:  Samples were analyzed by SDS PAGE (8% acrylamide) 
in 8 M urea. Proteins were transferred from the gels to nitrocellulose paper as 
described by Burnette (7) for 6-24 h. The nitrocellulose filters were incubated 
with hybridoma  supernatant  diluted  1:50 in 5%  BSA-Tris saline buffer (150 
mM NaCI, 100  mM Tris), rinsed, and then incubated  with  ~2~i-labeled goat 
anti-mouse IgG (~10  s cpm per 8 x  10 cm filter) in 5% BSA-Tris saline. 
Preparation of Tissues for Immunoblots:  Synaptosomes  were 
isolated from bovine brain by a modification of published procedures (13). The 
tissue was homogenized in a buffer of 0.32 M sucrose, l0 mM HEPES, and l0 
mM EGTA, pH 7.4 (2 g brain/10 ml buffer). The pellet obtained  by centrif- 
ugation of  the homogenate at 20,000 g for 20 rain was washed by centrifugation 
and resuspension in homogenization  buffer. 15-ml samples of the resuspended 
material were centrifuged at 80,000 g for 16 h in a discontinuous Ficoll gradient 
consisting of 8-ml layers of 2, 8, and 16% Ficoll in homogenization buffer. The 
synaptosome band was collected from the interface between 8 and 16% Ficoll. 
Chromaflin granule membranes prepared by the method of Trifaro and Dwor- 
kind (40) were a gift of Dr. Erik Schweitzer; membrane fractions from rabbit 
and chicken brain were generously donated by Dr. John Bixby, UCSF. 
Cell Culture:  AtT-20/D16V  cells were grown in  10% horse serum in 
Dulbecco's  minimal  essential  medium containing  4.5  g/liter  glucose (Dul- 
becco's minimum essential medium-H21)  at  15% CO2. The pheochromocy- 
toma cell line, PCI2, was obtained from UCSF tissue culture facility and grown 
in 10% fetal calf serum and 5% horse serum in Dulbecco's minimum essential 
medium-H21 without NGF, except for immunofluorescence  studies where 2.5S 
NGF was added at a concentration  of 100 ng/ml; HIT cells were grown in 15% 
heat-inactivated horse serum and 2.5% fetal calf serum in Dulbecco's minimum 
essential medium-HI6 (1  g/liter glucose); and GH3 cells were grown in  10% 
fetal calf serum in Dulbecco's minimum essential medium-H21  at 10% CO2. 
Superior  cervical  ganglion  neurons,  dissociated  from  l-2-d-old  rats,  were 
generously donated  by Arthur Lander  (UCSF). The neurons were plated  in 
medium containing  NGF on poly-d-lysine-coated  glass coverslips which had 
been pretreated with bovine corneal epithelium  conditioned  medium as previ- 
ously described (24) and fixed 24 h after plating for immunofluorescence. 
Metabolic  Labeling  with  [3SS]Methionine:  PC12  cells  were 
grown to confluence without NGF in  15 cm tissue culture  plates. Cells were 
labeled at 37"C with  l mCi [3SS]methionine/plate in medium containing one- 
twentieth the normal amount of methionine.  For long term labeling, cells were 
incubated for 5 h in [3~S]methionine  and extracted immediately, or chased for 
l h in normal medium and then extracted. Cells treated with tunicamycin were 
incubated with 5 #g/ml tunicamycin  in normal medium for 2 h before labeling 
was done. This concentration  of  tunicamycin does not inhibit protein synthesis 
in AtT-20 cells (A. Katzen and H.-P. Moore, unpublished  observations). For 
short term labeling (<l  h), cells were first incubated  for 20 min in medium 
with one-twentieth  normal methionine.  Cells were extracted with 2 ml/15 cm 
plate  of ice-cold lysis buffer (1%  Nonidet  P40, 0.4% deoxycholate,  66  mM 
EDTA,  l0 mM Tris-HCl, pH 7.4 [35]) containing  0.3 mg/ml phenylmethyl- 
sulfonyl fluoride and 0.3 mg/ml iodoacetimide. The cell extracts were clarified 
by centrifugation  at  12,000 g for 5 rain,  and the supernatants  were kept for 
analysis. 
Preparation of Monoclonal  Antibody  Immunobeads  and 
Imraunoprecipitation of SV2 Antigen:  A l-ml slurry of l0 mg/ml 
rabbit antimouse lmmunobeads was mixed with 2 ml of monoclonal superna- 
tant overnight  at 4°C. After incubation  with  the monoclonal  antibody,  the 
beads  were washed  three  times by centrifugation  and  resuspension  in  the 
original volume (10 mg/ml) ofimmunoprecipitation buffer (1% Nonidet P40, 
0.5%  deoxycholate,  0.1% SDS, 50  mM  Tris-HCl,  0.4  M  NaCI,  pH  7.4). 
Immunoprecipitations  were done by a modification of  the procedure of  Carlson 
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diluted 10-fold with 0. 1% BSA in immunoprecipitation  buffer, and mixed with 
50 ~1 of immunobeads/20 ug protein  overnight  at 4"C. Control  beads were 
prepared  with  a  monoelonal  antibody  to  a  glycoprotein  of elasmobranch 
synaptie vesicles (SV1) that does not crossreact with the mammalian nervous 
system. 
Immunoprecipitation of Sgnaptic Vesicles:  lmmunoprecipi- 
ration of  whole and sonicated vesicles  labeled by iodination with [~2Sl]diazotized 
iodosulfanilic acid was done as described by Carlson and Kelly (9) with the 
following modifications. Aliquots of labeled vesicles were incubated overnight 
with two different concentrations  of monoclonal supernatant  (0.5 or 1.0 ~l) or 
culture medium without antibodies at 4"C. 50 #l of  a l0 mg/ml slurry of rabbit 
antimouse Immunobeads was then added to each sample and incubated with 
rotation  for 3 h at 4"(2. The labeled beads were spun for l0 rain at  12,000 g 
through a pad of 12.5% Ficoll in 0.4 M NaO, l0 mM HEPES,  1% BSA, pH 
7.0, and washed three times with buffer. The  pelleted beads were counted and 
the amount of radiolabeled material associated with the beads was expressed as 
a percentage of the total tricholoracetic acid-precipitable  radioactivity present 
in the starting material. There was no significant difference in the percent of 
trichloroacetic acid-precipitable  counts bound to Immunobeads  prepared with 
two different concentrations  of monocional  supernatant. 
Other Techniques:  Proteins were determined by the method of  Brad- 
ford (4) by use of the Bio-Rad protein  assay reagent with BSA as a standard. 
Approximate M, in SDS PAGE was determined by preparation of a calibration 
curve based on the mobilities of  myosin (205,000), beta-galactosidase (116,000), 
phosphorylase B (97,400), bovine albumin (66,000), egg albumin (45,000), and 
carbonic anhydrase (29,000). 
RESULTS 
Monoclonal Antibodies Specific for Electric 
Organ Synaptic Vesicles 
We have generated monoclonal antibodies to unique com- 
ponents of cholinergic synaptic vesicles.  Mice were immu- 
nized with highly purified vesicles from the electric organ or 
the  elasmobranch  Discopyge  ommata  and  hybridoma cell 
lines were obtained by conventional techniques.  Antibodies 
secreted by these cell lines were tested for specific binding to 
purified electric organ synaptic vesicles using a  solid-phase 
radioimmunoassay. In a panel of six monoclonal antibodies 
specific for synaptic vesicles by solid-phase radioimmunoas- 
say, antibodies to one antigen, SV2, also showed wide cross- 
reactivity with the mammalian nervous system. Antibodies 
to  SV2  were  further  screened to  show that the  antibodies 
recognized  on  antigenic  determinant  that  co-purified with 
elasmobranch  synaptic  vesicle contents  during  permeation 
chromatography on controlled pore glass columns (Fig.  1). 
To  establish  the  location  of the  SV2  antigen  in  synaptic 
vesicles purified from the electric organ, we tested hybridoma 
supernatant to this antigen for its ability to precipitate intact 
or sonicated vesicles. Antibodies to the SV2 antigen were able 
to  precipitate  both  intact  and  sonicated  vesicles,  whereas 
antibodies to a proteoglycan-like material (SV 1  ) that is on the 
inside of synaptic vesicles (9) were able to precipitate vesicle 
membranes only when the vesicles had been sonicated previ- 
ously (Fig. 2). We saw consistent results with electron micros- 
copy (Fig.  3) using an immunoperoxidase technique to visu- 
alize antibody binding to nerve terminals in a preparation of 
gently homogenized electric organ (5). When nerve terminals 
were incubated with antibodies to the SV2 site,  little or no 
reaction product was found associated with intact nerve ter- 
minals. Occasionally, however, synaptic vesicles were heavily 
labeled with  reaction product in  nerve terminals that were 
apparently lysed  during preparation  (Fig.  3b).  In contrast, 
antibodies to the SV l  site (Fig.  3 a) bound to the outside of 
nerve terminals as we  have previously described  (5).  This 
antigen,  which  is  on  the  inside  of synaptic vesicles (9),  is 
accessible on the outside of nerve terminals, presumably as a 
result  of exocytosis of vesicle membrane.  Unlike  the  SV2 
antigen, the SV l antigen was not detectable in damaged nerve 
terminals, presumably because the vesicle membrane remains 
intact. Thus, the SV2 antigenic site is on the cytoplasmic face 
of synaptic vesicle membranes whereas the SV 1 site is on the 
luminal face of the vesicle membrane. 
The SV2 Antigenic Site Is a Nerve Terminal 
Marker in Mammalian and Amphibian 
Nervous Systems 
Monoclonal  antibodies to  electric  organ  synaptic vesicle 
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FIGURE  1  Co-purification of monoclonal antibody binding with synaptic vesicles during permeation chromatography. A sucrose 
gradient enriched fraction (10) was further fractionatecl  on controlled pore glass 3000.  Elution of membranes was monitored by 
light scattering at 310 nm (H) and ATP content of synaptic vesicles was monitored by absorbance at 260 nm (- -  -) corrected 
for light scattering (9). The antigenicity of every other column fraction was measured by solid-phase radioimmunoassay on 
microtiter plates (8). Each open circle represents the average of two adjacent data points. The binding of anti-SV2 (O) to vesicle 
membranes coelutes quite closely with the peak of vesicle contents. The maximum binding of anti-SV2 was 4,000 cpm/#l. 
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of other species by indirect immunofluorescence on cryostat 
sections  of formaldehyde-fixed rat  spinal  cord.  Only  the 
monoclonal antibody to the SV2 antigen showed detectable 
binding.  The  pattern  of binding  seen  with  this  antibody 
suggests  that  it is  not restricted to any  one class  of nerve 
terminals but rather is a universal marker for vertebrate nerve 
terminals. Small, punctate fluorescence was seen in all regions 
of the rat and frog spinal cord. Label was particularly heavy 
in the substantia gelatinosa of the dorsal horn, and, in the 
ventral horn of the spinal cord, the cell bodies and dendrites 
of the motor neurons were outlined by fluorescent spots (Fig. 
4, a  and b). Little specific fluorescence was seen in the neu- 
ronal cytoplasm. The antigen was not restricted to neurons 
that  innervate  the  peripheral  nervous  system  because  the 
monoclonal antibody to SV2 bound to both the giomerular 
and molecular layers of  the rat cerebellum and all the synaptic 
layers of the hippocampus (Fig. 4, c and d). The SV2 antigen 
was  also  found  in  amphibian  central  nervous  system,  as 
monoclonal antibody to SV2 bound to the synaptic regions 
30 
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FIGURE  2  Immunoprecipita- 
tion of intact and sonicated ves- 
icles  with  monoclonal antibod- 
ies bound to Immunobeads. T251- 
labeled intact or sonicated syn- 
aptic  vesicles  were  incubated 
with  monoclonal  antibodies 
bound to Sepharose beads (SV1 
or  SV2). Control  beads  (reed) 
were preincubated with culture 
medium  without  antibodies. 
Each bar is the average of dupli- 
cate samples in one experiment. 
]he percentage of total trichlo- 
roacetic acid-precipitable radio- 
activity (78,526  cpm)  immuno- 
precipitated by each antibody is 
shown  for  intact  or  sonicated 
vesicles. 
of the bullfrog retina, the inner and outer plexiform layers 
(Fig. 4, e and f), and to synapses in the frog spinal, cord (data 
not shown). 
To obtain further evidence for the association of SV2 with 
synaptic vesicles in the mammalian nervous system, we ex- 
amined the binding of antibodies to SV2 to thin sections of 
Lowicryl-embedded  rat cerebellum and visualized the binding 
sites  with goat anti-mouse IgG adsorbed to colloidal gold. 
Gold particles were concentrated over presynaptic elements, 
which could be easily identified by the darkly stained pre- and 
postsynaptic densities (Fig. 5, a-c), and also over varicosities 
(Fig.  5a).  We found  few gold  particles over mitochondria 
within nerve terminals (Fig.  5, b and c), which suggests that 
the antigen is associated predominantly with synaptic vesicles. 
To obtain some quantitative measure of the synaptic specific- 
ity of antibody binding in the cerebellum, we compared the 
density of  gold particles over synaptic terminals to the density 
of the  total  number  of gold  particles  in  a  given  field,  as 
described in Materials and Methods. We chose this method 
of comparison  because  the  preservation  of ultrastructural 
detail was variable throughout the section. Consequently, the 
binding sites  of all the gold particles could not be assigned 
unambiguously to  synaptic or nonsynaptic structures. The 
density of gold particles located over presynaptic terminals 
was 4.2 times greater than the average density of  gold particles. 
Furthermore, control sections incubated with culture medium 
alone had <4% of  the total number of gold particles seen with 
antibodies to SV2. 
Cross-reaction with Other Secretory Cells 
Because  cells  with  the  regulated  secretory pathway  are 
similar in many ways, we asked if the SV2 antigen was also 
present in secretory vesicles of non-neural secretory cells. The 
antibody showed specific binding to cells in several types of 
endocrine tissues  in the rat, including the adrenal, pituitary, 
and pancreas. In the adrenal gland, the antibody bound to 
the endocrine cells  of the  medulla but  not to the  steroid- 
FIGURE  3  Localization of antibody binding sites on intact and disrupted nerve terminals with immunoperoxidase techniques. 
After incubation of electric organ nerve terminals with monoclonal antibodies to SVl (a), peroxidase  reaction product (arrowhead) 
was associated with the outside of the presynaptic membrane. In contrast, after incubation with antibody to SV2 (b), the reaction 
product appeared to  be  localized to the  outside of  synaptic vesicles  in  nerve  terminals that were apparently lysed  during 
preparation of the tissue, x  31,920. 
BUCKLEY AND KELLY Secretory Vesicle-specific Glycoprotein  11287 FIGURE 4  Immunofluorescent staining of  mammalian and  amphibian nerve terminals with  monoclonal antibody to  SV2.  (a) 
Dorsal horn of rat spinal cord. (b) Ventral horn of rat spinal cord. (c) Rat cerebellum; g, granular layer; m, molecular layer. (d) CA1 
region of the rat hippocampus. (e) Bullfrog retina. (f) Corresponding phase picture of e; i, inner plexiform layer; o, outer plexiform 
layer. (a-c)  Bar, 50/~m. x  140. (d-f)  Bar, 50 #m. x  300. 
producing cells  of the cortex, presumably because they lack 
secretory vesicles (Fig.  6 c). It also bound strongly to cells of 
the intermediate lobe of the pituitary and less  strongly, but 
detectably, to the cells of the anterior lobe (Fig. 6, a and b). 
The pancreas is composed of two types of secretory cells. 
The acinar cells, classified  as exocrine, surround small groups 
of islet cells which are considered endocrine.  In sections of 
pancreas, only the islet cells (clearly distinguishable in phase 
microscopy by the absence of  the phase dense granules present 
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in the acinar cells [Fig. 6)q) showed fluorescent staining after 
incubation  with the  monoclonal antibody to SV2,  whereas 
the acinar cells had no detectable fluorescence (Fig.  6, d and 
e).  It would  seem therefore that  the  SV2  antigen  is  not  a 
universal  marker  for  cells  with  regulated  secretion  but  is 
specific  for neurons and endocrine cells.  Other secretory tis- 
sues  that  did  not  contain  detectable  amounts  of the  SV2 
antigen were rat submaxillary salivary gland, thyroid follicular 
cells, liver, and lymph node (data not shown). FIGURE  5  Localization of binding sites of antibody to the SV2 glycoprotein in rat cerebellum with colloidal gold. Gold  particles 
are concentrated over presynaptic terminals (a-c) but can also be seen over structures resembling varicosities (a). x  50,160. 
Expression  of the SV Antigen in Cultured Cells 
To study the biogenesis and function of the SV2 antigen it 
would be an obvious advantage if the antigen were expressed 
in  neural  and  endocrine cells in  culture.  Several cell  types 
were tested  and  found  to  have  the  SV2  antigen.  Neurons 
dissociated  from superior  cervical  ganglia  of neonatal  rats 
were plated into NGF and fixed 24 h later during the period 
of maximal neurite outgrowth. Specific immunofluorescence 
was seen in some, but not all, of the growth cones (Fig.  7 d). 
Furthermore,  a  perinuclear  staining  could  be  seen  in  the 
neuronal cells which may represent an accumulation of anti- 
gen in the Golgi region (Fig. 7 b). 
The SV2 antigen was also present in established cell lines. 
The  pheochromocytoma cell  line,  PC12,  was  grown  for  a 
week in the presence of NGF. After incubation with mono- 
clonal antibodies (mAb) to SV2, there was strong fluorescence 
of the  varicosities in  these  cultures  and  in  the  perinuclear 
region of the cell  cytoplasm (Fig.  8 a). Three endocrine cell 
lines also stained  with  mAb to  SV2.  AtT-20  cells,  derived 
from mouse anterior pituitary, synthesize, store, and secrete 
the hormone ACTH (15,  34). These cells bound antibody to 
SV2  specifically  at  the  tips  of the  short  processes,  where 
secretory vesicles are known to accumulate (21)  and in the 
perinuclear  cytoplasm,  perhaps  associated  with  the  Golgi 
apparatus (Fig. 8 c). This pattern of staining was similar to the 
pattern seen when AtT-20 cells were incubated with an affin- 
ity-purified antiserum  to ACTH (Fig.  8d).  GH3 cells,  also 
derived  from  the  anterior  pituitary,  which  secrete  growth 
hormone and prolactin,  and  HIT cells,  an insulin-secreting 
cell line, both contained the antigen by immunofluorescence 
techniques (Fig.  8, b and e). 
Identification  of SV2 as a Glycoprotein 
In the electric fish  synaptic vesicles,  the SV2 antigen  had 
the  broad  electrophoretic mobility  often  associated with  a 
glycosylated protein (Fig.  9,  lane c). To determine the bio- 
chemical characteristics of the mammalian SV2 antigen, we 
compared the mobility of the SV2 antigen from a variety of 
tissues in SDS PAGE by Western blotting techniques. Fig. 9 
shows  that  in  all  samples,  the  SV2  antigen  migrates  as  a 
similarly broad band. The predominant species in the mam- 
malian and avian brains had Mr's of -75,000 to 85,000 (Fig. 
9, lanes d-g). SV2 antigen from endocrine cells appeared to 
have a higher molecular weight range of ~ 105,000-110,000, 
regardless of the species (Fig. 9, lanes h-j). The Mr of the SV2 
antigen in electric fish brain (Fig. 9, lane a) and electromotor 
nucleus (Fig. 9, lane b) was slightly lower than the Mr of SV2 
antigen in purified synaptic vesicles (Fig. 9, lane c). To deter- 
mine if the wide range of apparent molecular weight could 
arise because the SV antigen is highly glycosylated, we grew 
PC12  cells in  the  presence of tunicamycin, which  prevents 
the  addition  of N-linked  sugars  (19),  and  [35S]methionine. 
After  tunicamycin  treatment,  the  antigen  immunoprecipi- 
tated by mAb to SV2 appeared as a single band at ~62,000 
Mr (Fig.  10, lower arrowhead, lane c), in contrast to the antigen 
from untreated cells, which ran at ~ 110,000  (Fig.  10, arrow, 
lane b). Both were absent in the control (lane d). 
The identity of the 62,000 Mr protein as a nonglycosylated 
or  precursor  form  of the  SV2  antigen  was  supported  by 
comparison of the mobility of labeled material extracted from 
cells immediately after a 30-45 min pulse of [35S]methionine 
to  material  from cells that  were labeled  for  5  h  and  then 
chased for an hour in medium without [aSS]methioniaae. Fig. 
10  shows  that  after  short  term  labeling  the  SV2  antigen 
appeared as a single band at lower molecular weight (-64,000, 
lane a), whereas the higher molecular weight form appeared 
(lane b) after much longer labeling. 
DISCUSSION 
The  similarities  between  the  calcium-regulated  exocytotic 
events in neuronal, endocrine, and exocrine cells suggests that 
some of  the molecular machinery involved in regulated release 
might be shared. If  the shared molecules are highly conserved 
then there should be common antigenic determinants in all 
cells that have the regulated pathway. In searching for such a 
determinant, we have identified a transmembrane glycopro- 
tein present in highly purified synaptic vesicles from elasmo- 
BUCKLEY AND KELLY  Secretory  Vesicle-specific Glycoprotein  1289 FIGURE  6  Binding to endocrine cells of antibody to the SV2  antigen. (a)  Immunofluorescence staining of the rat  intermediate 
pituitary with monoclonal antibody to SV2.  (b) Immunofluorescence of the rat anterior pituitary. (c)  Immunoperoxidase staining 
of the adrenal medulla (m). The cortical cells (cot)  are unstained. (d and e) Immunofluorescence staining of rat pancreas. Only 
the islet cells are fluorescent after incubation with antibody to SV2.  (f)  Phase picture corresponding to fluorescent section shown 
in e. Note that the cells that are not fluorescent in e contain many phase dense granules, a characteristic of the exocrine cells in 
the pancreas. Bars: (a and b) 25 ,am; (c) 50 ,am; (d-f) 25 ,am. (a and b) x  560. (c) x  300. (d-f)  x  800. 
branch electric organ that,  by immunofluorescence and im- 
munoblotting techniques,  was also present in a  wide variety 
of nerve  terminals  in  the  central  and  peripheral  nervous 
system and  in several  types of endocrine, but  not exocrine, 
cells. 
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We believe for several reasons that the antigen recognized 
by the anti-SV2  monoclonal antibody is glycosylated. First, 
the mobility of the protein in a  variety of tissues and species 
in SDS PAGE was heterogeneous (Fig. 9). Second, when PC 12 
cells were grown in the presence of tunicamycin, a drug that FIGURE  7  Immunofluorescent staining of dissociated sympathetic neurons  in  culture with  monoclonal antibody to  the  SV2 
antigen. (a) Phase picture of a neuronal cell body (left) and an adjacent non-neuronal cell. (b) Corresponding fluorescence picture. 
Only the neuron shows detectable immunofluorescence, which is localized to the perinuclear region of the cytoplasm. (c) Phase 
picture of neuronal growth cone. (d) Fluorescent staining of the growth cone shown in c. Bar, 10 p,m. x  1,100. 
blocks the addition of asparagine-linked sugars, the apparent 
molecular weight of the protein in SDS PAGE was reduced 
by ~30,000 (Fig.  10). Furthermore, the short and long term 
labeling experiments showed that the protein migrated as a 
single  band with an Mr of 64,000  after short term labeling 
and appeared as a higher molecular weight form after longer 
labeling periods (Fig.  10, lanes a  and b). The slightly higher 
molecular weight of this precursor form of the SV2 protein 
as compared with the molecular weight of the protein synthe- 
sized  in  the  presence  of tunicamycin  (Fig.  10,  lane  c)  is 
probably due to co-transational glycosylation of the precursor 
protein (19). 
Because glycosylation of most, and probably all,  proteins 
occurs on the luminal side of the membrane, and the anti- 
bodies to SV2 bound to the cytoplasmic side of the  vesicle 
membrane (Figs. 2 and 3), we assume that the SV2 glycopro- 
tein spans the vesicle membrane. Furthermore, the antigen is 
recovered in the detergent phase after solubilization of bovine 
brain synaptosomes with Triton X-114 (C.  K. Kassenbrock, 
unpublished  observations),  as  is  characteristic  of  integral 
membrane proteins (3). It should therefore also be possible to 
generate antibodies to the luminal domain. Such antibodies 
would be of great value in determining the fate of the glyco- 
protein after it is externalized by exocytosis. They also would 
facilitate the selection of variant strains of cells that lack the 
protein. 
Comparison of the mobilities of the SV2 glycoprotein from 
endocrine  and  neural  sources  suggests  that  the  protein  in 
endocrine secretory granules differs slightly from that in neu- 
ronal synaptic vesicles. Although there was some variation in 
the SV2 antigen in brain homogenates from different species, 
the differences between the electrophoretic mobility in bovine, 
chicken,  mouse,  and  rabbit  brain  were slight as  compared 
with the difference between the average of the brain samples 
and  that  for three endocrine cell types: PCI2  cells,  AtT-20 
cells,  and bovine adrenal  chromat~n cells (Fig.  9).  Further- 
more, a  direct comparison  of bovine brain  (Fig.  9,  lane g) 
and bovine adrenal chromaffin cells (Fig.  9, lane h) demon- 
BUCKLEY AND  KELLY  Secretory Vesicle-specific  Glycoprotein  1291 FIGURE  8  Indirect  immunofluores- 
cence  of  endocrine  cell  lines  with 
monoclonal antibody to  SV2  antigen. 
(a)  Pheochromocytoma  (PC12)  cells; 
(b)  HIT  cells;  (c)  AtT-20  cells  stained 
with  mAb  to  SV2;  (d)  AtT-20  cells 
stained with affinity-purified antiserum 
to ACTH;  (e) GH3  cells.  (a,  c,  and d) 
Bar,  25  /~m. x  560.  (b and  e)  Bar,  25 
~m. x  840. 
strates  that  the  difference  cannot  be  explained  by  species 
variation alone. Alternatively, the variation in Mr of the SV2 
antigen may be correlated with central and peripheral nervous 
system. The difference in molecular weight of  the SV2 antigen 
in different tissues and species is probably due to the degree 
of glycosylation of the same polypeptide chain, as is the case 
with NCAM, a glycoprotein involved in neuronal adhesion. 
This glycoprotein has different molecular weights in embry- 
onic chick brain and retina, but removal of sialic  acid with 
neuraminidase converts both forms of the  molecule to the 
same molecular weight  (17).  The  possibility  has  not  been 
eliminated, however, that the apparent difference in Mr of the 
SV2 antigen in different tissues is due not to glycosylation but 
to differences in the polypeptide sequence or length. 
Only one other membrane protein has been found in both 
synaptic vesicles and endocrine secretory granules. The pro- 
tein, described by Matthew et al. (31) has a molecular weight 
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of 65,000 in SDS PAGE. The 65,000-D protein has a distri- 
bution in rat nervous system and endocrine tissue that is very 
similar to that described here for the SV2 glycoprotein. Unlike 
the SV2 antigen, however, the protein described by Matthew 
et al.  (31)  could  not  be detected  in  electric organ synaptic 
vesicles (30) and its molecular weight is the same in all species 
of brains.  The  two proteins also appear to  be  in  different 
populations  of bovine brain  coated  vesicles (33).  Synaptic 
terminals throughout the central and peripheral nervous sys- 
tem also contain a third protein, synapsin I (11).  Unlike the 
65,000-D protein and the SV2 glycoprotein, synapsin I is a 
peripheral  membrane protein  and  is  not  detectable  in  the 
adrenal medulla, which suggests that it is associated only with 
neuronal synaptic vesicles and not with endocrine secretory 
granules (11). 
The absence of the SV2 antigen from exocrine cells could 
reflect a function unique to secretion from neural and endo- FIGURES  9  Electrophoretic mobility of SV2 antigen in various spe- 
cies and tissues. Membranes or vesicles were prepared from various 
tissues, subjected to SDS  PAGE,  transferred to nitrocellulose, and 
visualized by blotting with  mAb to SV2 and radioactive goat anti- 
mouse IgG. Approximately 20-60 p.g of protein (except lane c, 1 /~g 
of purified synaptic vesicles) was loaded per lane, and two different 
exposures of the same autoradiogram were made to equalize the 
density of bands.  Lanes: (a) electromotor nucleus (Discopyge om- 
mata); (b) brain (Discopyge ommata); (c) synaptic vesicles (Discopyge 
ommata); (d) chicken brain membranes; (e) rabbit brain membranes; 
(f)  mouse  brain  membranes; (g)  bovine  brain  synaptosomes; (h) 
chromaffin  granules (bovine); (i)  PC12  membranes (rat pheochro- 
mocytoma); and (J) ART-20 membranes (mouse cell line). 
crine cells. Alternatively, the protein and its function may be 
shared by both types of secretory granules,  but the antigenic 
determinant may not be conserved in exocrine cells. Because 
of the similarities in the mechanisms of secretion in endocrine 
and  exocrine  cells,  it  has  been  suggested  that  a  common 
secretory stem  cell gave rise  to exocrine cells and  a  neural- 
endocrine precursor cell. According to this hypothesis,  neu- 
rons and endocrine cells then differentiated from each other 
(25).  Several  lines  of evidence  suggest  that  endocrine  and 
neural  cells are  more  closely related  to  each  other  than  to 
exocrine cells. Both neurons and endocrine cells secrete many 
of the  same  peptides  and  hormones  (23,  25);  at  least  two 
secretory  vesicle  membrane  proteins  (the  65,000-D  protein 
and the SV2 glycoprotein) are common to both types of cells 
but absent from exocrine cells (reference 31  and this paper); 
and neuron-specific enolase, previously thought to be specific 
for neurons, has been found in a wide variety of the endocrine 
cells but not exocrine cells (2, 36). If endocrine and neuronal 
cells are closely related by evolution, the absence of the SV2 
antigenic site in exocrine cells could result from tissue specific 
expression of the protein rather than  from a  basic difference 
in exocytotic mechanisms. 
The widespread  distribution  of the  SV2  antigen  in  tissue 
ranging from the elasmobranch to the mammalian brain, and 
its presence in all neuronal and endocrine tissue we examined, 
suggests a  conserved function for the SV2 glycoprotein. The 
conserved domain is on the portion of the molecule that faces 
the cytoplasm.  One explanation  for a  conserved domain  on 
the cytoplasmic surface of secretory vesicles is that  it allows 
FIGURE  10  Immunoprecipitation 
of [3SS]methionine-labeled SV2 an- 
tigen from PC12 cells. Lane a, PC12 
cells were  labeled for 45  rain,  ex- 
tracted immediately, and  immuno- 
precipitated  with  SV2  immuno- 
beads. The labeled material immu- 
noprecipitated  by  monoclonal  an- 
tibody to SV2 appeared as a narrow 
band  at  M,  64,000  (upper  arrow- 
head). Lane b,  PC12  cells were la- 
beled for 5 h and chased for 1 h in 
the absence of [3SS]methionine but 
with  normal  amounts  of cold  me- 
thionine.  The  immunoprecipitated 
material shows an additional band, 
which  runs  more  slowly  (Mr 
-110,000)  and  has a greater range 
of electrophoretic mobility (arrow). 
Lane c,  PC12  cells were pretreated 
with tunicamycin and labeled for 5 
h  with  [35S]methionine. The  mate- 
rial immunoprecipitated by SV2 im- 
monobeads from these cells runs as 
a  single band  of  Mr 62,000  (lower 
arrowhead). Lane d,  control.  PC12 
cells were  labeled as  in  b  but  im- 
munoprecipitated with  SVl  immu- 
nobeads. 
interaction with another conserved molecule, for example, a 
component of the cytoskeleton or the plasma membrane. The 
existence of such  interactions  might be testable by microin- 
jection, reconstitution, or a  mutational approach. 
We thank Leslie Spector for her skillful and patient preparation of 
the manuscript; Steven Carlson for his extremely generous contribu- 
tion  of the  data  in  Figure  2  on  immunoprecipitation  of synaptic 
vesicles; Lois  Clift-O'Grady  for  assistance  with  the  bovine  brain 
synaptosomes  and  for generation  of an  endless supply  of synaptic 
vesicles; Deborah Crumrine for preparation of the Lowicryl sections; 
and Pico Caroni and Erik Schweitzer for their participation in gen- 
erating the monoclonal antibodies. We are also grateful to the mem- 
bers of the Kelly lab and Jeffrey Boone Miller for critical reading of 
the  manuscript  and  many  helpful  suggestions.  We  thank  David 
Shelton for his generous girl of 2.5S NGF and  Arthur Lander  for 
donating sympathetic neurons and bovine corneal epithelium con- 
ditioned medium. 
A  preliminary  account  of this  work  was  presented  at  the  14th 
Annual Meeting of the Society for Neuroscience, Anaheim, Califor- 
nia, October 1984. 
Received for publication  3  October  1984,  and  in  revised form  11 
December 1984. 
REFERENCES 
1. Altman,  L. O., B. G. Schneider,  and D. S. Papermaster. 1983. Rapid (4 hr) method  for 
'embedding  tissues in Lowicryl  for immunoelectron  microscopy.  J. Cell Biol. 97:309a. 
(Abstr.} 
2.  Bishop,  A., J. Polak, P. Facer,  G.-L.  Ferri,  P. J. Maranges, and A. Pearse. 1982. Neuron 
specific  enolase: a common marker for the endocrine cells  and innervation  of the gut 
and pancreas. Gastroenterology. 83:902-915. 
3.  Bordier, C.  1981. Phase separation of integral membrane proteins in Triton X-114 
solution. J. Biol. Chem. 256:1604-1607. 
4.  Bradford,  M. M. 1976. A rapid and sensitive  method  for the quantitation of microgram 
quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 
72:248-254. 
5. Buckley,  K. M., E. Schweitzer,  G. Miljanich,  L. Cliff-O'Grady,  P. Kushner,  L. Reichardt, 
and R. B. Kelly. 1983. A synaptic  vesicle  antigen is restricted  to the junctional  region  of 
the presynaptic  plasma membrane. Proc. NatL Acad. Sci. USA. 80:7342-7346. 
6. Burke, B., G. Griffiths, H. Regglo,  D. Louvard, and G. Warren. 1982. A monoclonal 
antibody against a 135K Golgi membrane protein. EMBO (Eur MoL BioL Soc.) J. 
1:1621-1628. 
7. Burnette, W. N.  1981. "Western Blotting":  electrophoretic  transfer of proteins from 
BUCKLEY AND KELLY  Secretory  Vesicle-specific Glycoprotein  1293 sodium  dodecyl  sulfate-polyacrylamide  gels  to  unmodified  nitrocellulose  and  radio- 
graphic detection with antibody and radioiodinated protein A. Anal.  Biochem.  I 12:195- 
203. 
8.  Carlson,  S.S., and  R.  B.  Kelly.  1980.  An antiserum specific  for eholinergic synaptic 
vesicles from electric  organ. J. CellBiol.  87:98-103. 
9.  Carlson, S. S., and R. B. Kelly.  1983. A highly antigenic proteoglycan-like  component 
of cholinergic synaptie vesicles. J. Biol.  Chem. 258:11082-11091. 
10.  Carlson, S. S., J. A. Wagner, and R. B. Kelly  1978. Purification ofsynaptic vesicles from 
elasmobranch electric  organ and the use of biophysical  criteria to demonstrate purity. 
Biochemistry.  17:1188-1199. 
11.  de Camilli, P.,  R. Cameron, and P. Greengard.  1983.  Synapsin I (Protein  I), a  nerve 
terminal-specific phosphoprotein.  I. Its general distribution in synapses of the central 
and  peripheral  nervous system demonstrated  by  immunofluorescence  in frozen  and 
plastic  sections.  J. Cell BioL 96:1337-1354. 
12.  Fazekas de St. Groth, S., and D. Scheidegger.  1980. Production of monoclonal antibod- 
ies: strategy and tactics..L lmmunol.  Methods. 35:1-21. 
13.  Gray, E. G., and V. P. Whittaker.  1962. The isolation  of nerve endings from brain: an 
electron  microscopic study of cell fragments derived by homogenization and centrifuga- 
tion. J. Anat.  96:79-88. 
14.  Green, R., and D. Shields.  1984. Somatostatin discriminates between the intracellular 
pathways of secretory and membrane proteins.  J. Cell Biol. 99:97-104. 
15.  Gumbiner,  B., and R.  B. Kelly.  1981.  Secretory  granules of an anterior pituitary cell 
line, ART-20, contain only mature forms ofcortieotropin and beta-lipotropin.  Proc NatL 
Acad Sci.  USA.  78:318-322. 
16.  Gumbiner,  B.,  and  R.  B.  Kelly  1982. Two distinct intracellular  pathways transport 
secretory  and  membrane glycoproteins  to  the surface of pituitary  tumor cells.  Cell. 
28:51-59. 
17.  Hoffman, S., B. C. Sorkin, P. C. White, R. Brackenbury, R. Mallhammer, U. Rutishau- 
ser,  B. A.  Cunningham,  and G.  M.  Edelman.  1982. Chemical characterization  of a 
neural cell adhesion molecule purified  from embryonic brain membranes. J. BioL Chem. 
257:7720-7729. 
18.  Hopper, J., S. Carlson, and R. B. Kelly  1980.  Antibodies to synaptic vesicles purified 
from Nareine electric  organ bind a subclass  of mammalian nerve terminals. J  Cell Biol. 
87:104-I 13. 
19.  Hubbard,  S. C.,  and  R. J.  lvalt.  1981. Synthesis and  processing of asparagine-linked 
oligosaccharides.  Annu. Rev.  Biochem.  50:555-583. 
20.  Johnson,  G.  D.,  R.  Davidson,  K.  McNamee,  G.  Russell,  D.  Goodwin,  and  E.  J. 
Holborow.  1982. Fading of immunofluorescence  during microscopy: a  study of the 
phenomenon and its remedy. J. lmmunoL Methods.  55:231-242. 
21.  Kelly, R. B., K. M. Buckley,  T. Burgess, S. S. Carlson, P. Caroni, J. Hopper, A. Kalzen, 
H.-P. Moore, S. Pfeffer, and T. Schroer 1983. Membrane traffic in neurons and peptide- 
secreting cells. Cold Spring  Harbor Symp. Quant.  BioL 48:697-705. 
22.  Kohler,  G,  and  C.  Milstein,  1976.  Derivation of specific  antibody  producing tissue 
culture and tumor lines by cell fusion.  Eur. J. lmmunoL  6:511-519. 
23.  Krieger,  D.  T.  1983. Brain  peptides:  what,  where  and  why? Science  (Wash.  DC). 
222:975-985. 
24.  Lander, A. D., D. Fujii, D. Gospodarowicz, and L. Reichardt.  1982. Characterization 
of a  factor that  promotes  neurite outgrowth:  evidence linking activity to  a  heparan 
sulfate  proteoglycan.  J. Cell Biol. 94:574-585. 
25.  LeRoith, D., J. Shiloach,  and J. Roth.  1982.  Is there an earlier phylogenetic  precursor 
that is common to both the nervous and endocrine systems? Peptides.  3:211-215. 
26.  Lin,  J. J. C., and S. A. Queally.  1982. A monoclonal  antibody that recognizes Golgi- 
associated  protein of cultured fibroblast  cells. J. Cell Biol. 92:108-112. 
27.  Louvard,  D., C.  Morris, G. Warren, K. Stanley,  F.  Winker, and H. Raggm. 1983.  A 
monoclonal  antibody to the heavy chain of clathrin. EMBO (Eur.  Mol.  Biol.  Soc.)  J. 
2:1655-1664. 
28.  Louvard, D., H. Reggio, and G. Warren.  1982. Antibody to the Golgi complex and the 
rough endoplasmic reticulum. J. Cell Biol.  92:92-107. 
29.  Mains, R. E., and B. A. Eippor.  1976. Biosynthesis  of adrenocortieotropic  hormone in 
mouse pituitary tumor cells. J. Biol.  Chem. 25:4115--4120. 
30.  Matthew,  W.  D.  1981. Biochemical  studies  using monoclonal  antibodies  to  neural 
antigens. Ph.D. Thesis. University of California, San Francisco 1-347. 
31.  Matthew, W., L. Tsavaler, and L. Reichardt.  1981. Identification of a synaptic vesicle 
specific membrane protein with a wide distribution in neural and neurosecretory tissue. 
J. Cell Biol. 91:257-269. 
32.  Moore, H.-P.,  B. Gumbiner, and R. B. Kelly 1983. A subclass of proteins and sulfated 
macromolecules secreted  by ART-20 cells is sorted with adrenocorticotropin  into dense 
secretory  granules.  J. Cell BioL 97:810-817. 
33.  Pfeffer, S. R., and R. B. Kelly.  1985. The subpopulation  of brain coated vesicles that 
carries synaptic vesicle proteins contains two unique polypeptides.  Cell. In press. 
34.  Roberts,  J. L.,  M.  Phillips,  P.  A. Rosa, and  E.  Herbert.  1978. Steps involved in the 
processing of  common precursor forms o f adrenocorticotropin and endorphin in cultures 
of mouse pituitary cells. Biochemistry.  17:3609-3618. 
35.  Rose, J., and  S.  Bergmann.  1982.  Expression  from cloned  DNA of cell  surface and 
secreted  forms of the glycoprotein of vesicular stomatitis virus in eucaryotic cells.  Cell. 
30:753-762. 
36,  Schmechel,  D., P.  Marangos, and  M.  Brightman.  1978. Neuron specific  enolase  is a 
molecular  marker for  peripheral  and  central  neuroendocrine  cells.  Nature  (Lond.). 
276:834-836. 
37.  Smith, Z. D.,  F.  D'Eugenio-Gumkowski, K. Yanagisawa, and J.  D. Jamieson.  1984. 
Endogenous and monoclonal antibodies to the rat pancreatic acinar cell Golgi complex. 
J. Cell Biol. 98:2035-2046. 
38.  Tartakoff, A.,  P.  Vassalli,  and  M.  Detraz.  1978. Comparative studies of intracellular 
transport of secretory  proteins..L Cell BioL 79:694-707. 
39.  Tougard, C., D. Louvard, R. Picart, and A. Tixier-Vidal. 1983. The rough endoplasmic 
reticulum and the Golgi apparatus visualized using specific  antibodies in normal and 
tumoral prolactin  cells in culture.  J. Cell Biol. 96:1197-1207. 
40.  Trifaro, J. M., and J. Dworkind. 1970. A new and simple method for isolation  of adrenal 
chromaffin granules by means of an isotonic density gradient. Anal.  Biochem.  34:403- 
412. 
1294  T,E  JOURNAL  OF  CELL BIOLOGY • VOLUME  100,  1985 